GlassScriptPhysician profile
Alex B Mand
NPI 1073923454
$1,395.06
in general payments reported to CMS, 2019-2025
13 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $51.10 · 2021: $17.38 · 2022: $75.32 · 2023: $371 · 2024: $532 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $758.65 | 2020-2025 | Grafix Pl, Grafix, Collagenase Santyl |
| Stryker Corporation | $195.86 | 2020-2024 | Variax, Sonicfusion, Allowrap |
| Merck Sharp & Dohme LLC | $124.96 | 2019 | |
| Kerecis Limited | $73.11 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $39.64 | 2024 | |
| Advanced Oxygen Therapy INC. | $37.94 | 2022 | |
| Nevro Corp. | $37.80 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $26.69 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $26.18 | 2024 | Ingrezza |
| Organogenesis INC. | $20.40 | 2023 | Puraply |
| Bioventus LLC | $20.00 | 2023 | Exogen Ultrasound Bone Healing System |
| Hartmann USA, INC. | $18.66 | 2025 | Zetuvit Plus 10x10 P10 |
| Mckesson Patient Care Solutions INC. | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Mand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.